Cargando…
The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report
BACKGROUND: Li-Fraumeni syndrome is a cancer predisposition syndrome caused by germline TP53 tumor suppressor gene mutations, with no previous association with pancreatic neuroendocrine tumors (PNETs). Here we present the first case of PNET associated with Li-Fraumeni syndrome. CASE PRESENTATION: Th...
Autores principales: | Aversa, John G., De Abreu, Francine Blumental, Yano, Sho, Xi, Liqiang, Hadley, Donald W., Manoli, Irini, Raffeld, Mark, Sadowski, Samira M., Nilubol, Naris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106707/ https://www.ncbi.nlm.nih.gov/pubmed/32228502 http://dx.doi.org/10.1186/s12885-020-06723-6 |
Ejemplares similares
-
Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017) -
Li–Fraumeni-associated pancreatic neuroendocrine tumour and XAF1 p.Glu134Ter risk modifier variant
por: Riechelmann, Rachel P, et al.
Publicado: (2022) -
Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019) -
The first documentation of Li-Fraumeni syndrome in Korea.
por: Bang, Y. J., et al.
Publicado: (1995) -
Pediatric Case of Li–Fraumeni Syndrome in Honduras
por: Martínez-Beckerat, R., et al.
Publicado: (2021)